In the lung cancer mouse model, M2-type TAMs could accumulate in well-differentiated tumor vascular sites, and promote tumor vascular reconstruction and recurrence by secreting vascular endothelial growth factor-A (VEGF-A) (60). This evidence concerns the gene VEGFA and lung carcinoma.